{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:22:15Z","timestamp":1792167735862,"version":"4.4.0"},"reference-count":88,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute","award":["R01CA275128"],"award-info":[{"award-number":["R01CA275128"]}]},{"name":"CSHL Cancer Center","award":["5P30CA045508"],"award-info":[{"award-number":["5P30CA045508"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Prostate cancer (PCa) is one of the most common malignancies in men, and growing evidence implicates the gut microbiome as a significant, modifiable contributor to disease evolution and management. Dysbiosis influences PCa biology through effects on inflammation, immune regulation, metabolism, and hormone signaling. Microbial imbalance can promote systemic inflammation and increase intestinal permeability, activating immune signaling pathways such as NF-\u03baB\u2013IL-6\u2013STAT3. In parallel, microbiome-driven metabolic effects, including IGF-1 signaling and microbial androgen synthesis or recycling, may contribute to resistance to androgen deprivation therapy (ADT). Microbial metabolites, notably short-chain fatty acids (SCFAs) and trimethylamine N-oxide (TMAO), exert context-dependent effects on tumor growth, treatment resistance, and progression. Conversely, beneficial microbes have been associated with improved treatment sensitivity and immune regulation. Together, these insights support the gut microbiome as a potential biomarker and emerging therapeutic target in PCa. Modulation strategies, including diet, probiotics, antibiotics, and fecal microbiota transplantation (FMT), are being explored to improve treatment response and address resistance. As mechanistic evidence continues to grow, ongoing monitoring of the gut microbiome may help inform risk stratification and treatment optimization in prostate cancer.<\/jats:p>","DOI":"10.3390\/cancers18060998","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:49:24Z","timestamp":1773924564000},"page":"998","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Gut Microbiome in Prostate Cancer: Current Evidence and Emerging Opportunities"],"prefix":"10.3390","volume":"18","author":[{"given":"Jing","family":"Huang","sequence":"first","affiliation":[{"name":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5353-7827","authenticated-orcid":false,"given":"Xin-Hua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Northwell Cancer Institute, Northwell Health, New York, NY 11042, USA"},{"name":"Feinstein Institutes for Medical Research, Northwell Health, New York, NY 11030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4794-1559","authenticated-orcid":false,"given":"Lloyd C.","family":"Trotman","sequence":"additional","affiliation":[{"name":"Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Kai","family":"Tsao","sequence":"additional","affiliation":[{"name":"Northwell Cancer Institute, Northwell Health, New York, NY 11042, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zha, C., Peng, Z., Huang, K., Tang, K., Wang, Q., Zhu, L., Che, B., Li, W., Xu, S., and Huang, T. (2023). Potential Role of Gut Microbiota in Prostate Cancer: Immunity, Metabolites, Pathways of Action?. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1196217"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ladoukakis, E., Oliver, T., Wilks, M., Lane, E.F., Chinegwundoh, F., Shaw, G., and Nedjai, B. (2024). Exploring the Link Between Obligate Anaerobe-Related Dysbiosis and Prostate Cancer Development: A Pilot Study. Cancers, 17.","DOI":"10.3390\/cancers17010070"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e41141","DOI":"10.1097\/MD.0000000000041141","article-title":"Investigating the Correlation between Gut Microbiota and Prostate Cancer through a Two-Sample Mendelian Randomization Analysis","volume":"104","author":"Guo","year":"2025","journal-title":"Medicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e004191","DOI":"10.1136\/jitc-2021-004191","article-title":"Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy against Prostate Cancer","volume":"10","author":"Terrisse","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_5","first-page":"100420","article-title":"Advancing Prostate Cancer Treatment: The Role of Fecal Microbiota Transplantation as an Adjuvant Therapy","volume":"9","author":"Ebrahimi","year":"2025","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.molmed.2025.03.015","article-title":"New Insights into Gut Microbiota-Prostate Cancer Crosstalk","volume":"31","author":"Laaraj","year":"2025","journal-title":"Trends Mol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Trecarten, S., Liss, M.A., Hamilton-Reeves, J., and DiGiovanni, J. (2025). Obesity, Dietary Interventions and Microbiome Alterations in the Development and Progression of Prostate Cancer. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1448116"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40168-022-01289-w","article-title":"Gut Dysbiosis Promotes Prostate Cancer Progression and Docetaxel Resistance via Activating NF-\u03baB-IL6-STAT3 Axis","volume":"10","author":"Zhong","year":"2022","journal-title":"Microbiome"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/jnci\/djt300","article-title":"Human Gut Microbiome and Risk for Colorectal Cancer","volume":"105","author":"Ahn","year":"2013","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"155621","DOI":"10.1016\/j.phymed.2024.155621","article-title":"Gut Microbiome and Metabolomic Profiles Reveal the Antiatherosclerotic Effect of Indole-3-Carbinol in High-Choline-Fed ApoE\u2212\/\u2212 Mice","volume":"129","author":"He","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4111\/icu.20220370","article-title":"Role of Microbiome and Its Metabolite, Short Chain Fatty Acid in Prostate Cancer","volume":"64","author":"Yang","year":"2023","journal-title":"Investig. Clin. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Jing, L., Jin, S., Fu, C., Liu, B., Shen, Y., Li, M., Zhang, Y., and Feng, N. (2025). Gut Microbiota Derived Metabolite Trimethylamine N-Oxide Influences Prostate Cancer Progression via the P38\/HMOX1 Pathway. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1526051"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.urolonc.2024.12.001","article-title":"Diet and the Microbiome as Mediators of Prostate Cancer Risk, Progression, and Therapy Response","volume":"43","author":"Faiez","year":"2025","journal-title":"Urol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.5534\/wjmh.240024","article-title":"The Relationship between Gut Microbiota and Prostate Health","volume":"42","author":"Pak","year":"2024","journal-title":"World J. Men\u2019s Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/pros.24756","article-title":"Influence of Microbiome in Intraprostatic Inflammation and Prostate Cancer","volume":"84","author":"Prakash","year":"2024","journal-title":"Prostate"},{"key":"ref_16","first-page":"501748","article-title":"Gut Microbiota and Prostate Cancer: An Analysis of Bacterial Communities across Various Clinical Scenarios","volume":"49","year":"2025","journal-title":"Actas Urol. Esp."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2341717","DOI":"10.1080\/19490976.2024.2341717","article-title":"An Emerging Strategy: Probiotics Enhance the Effectiveness of Tumor Immunotherapy via Mediating the Gut Microbiome","volume":"16","author":"Jiang","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Magashi Ali, M.A., and Abdulkadir, S.A. (2025). Modulating Prostate Cancer Therapy Through the Gut Microbiome: A Comprehensive Review. Cancers, 17.","DOI":"10.3390\/cancers17233842"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sakellakis, M., Resta, P., Papagianni, E., Procter, K.A., Belouka, I., Gioti, K., Anthouli-Anagnostopoulou, F., Chaniotis, D., and Beloukas, A. (2025). Decoding Microbiome\u2019s Role in Prostate Cancer Progression and Treatment Response. Diseases, 13.","DOI":"10.3390\/diseases13090294"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kim, S.J., Park, M., Choi, A., and Yoo, S. (2024). Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities. Pharmaceuticals, 17.","DOI":"10.3390\/ph17010112"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Pei, X., Liu, L., and Han, Y. (2025). Advances in Human Microbiome and Prostate Cancer Research. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1576679"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1210\/en.2015-1713","article-title":"Androgen Deficiency Exacerbates High-Fat Diet-Induced Metabolic Alterations in Male Mice","volume":"157","author":"Dubois","year":"2016","journal-title":"Endocrinology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/diabetes.54.4.1000","article-title":"Androgen Receptor Null Male Mice Develop Late-Onset Obesity Caused by Decreased Energy Expenditure and Lipolytic Activity but Show Normal Insulin Sensitivity With High Adiponectin Secretion","volume":"54","author":"Fan","year":"2005","journal-title":"Diabetes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2017.08.039","article-title":"The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study","volume":"111","author":"Golombos","year":"2018","journal-title":"Urology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","article-title":"Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer","volume":"74","author":"Liss","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.21037\/tau-20-566","article-title":"Compositional Differences of Gut Microbiome in Matched Hormone-Sensitive and Castration-Resistant Prostate Cancer","volume":"9","author":"Liu","year":"2020","journal-title":"Transl. Androl. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100928","DOI":"10.1016\/j.neo.2023.100928","article-title":"Gut Microbiota-Derived Short-Chain Fatty Acids Promote Prostate Cancer Progression via Inducing Cancer Cell Autophagy and M2 Macrophage Polarization","volume":"43","author":"Liu","year":"2023","journal-title":"Neoplasia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1111\/cas.14998","article-title":"The Gut Microbiota Associated with high-Gleason Prostate Cancer","volume":"112","author":"Matsushita","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1038\/s41467-024-45332-w","article-title":"The Gut Microbiome-Prostate Cancer Crosstalk Is Modulated by Dietary Polyunsaturated Long-Chain Fatty Acids","volume":"15","author":"Lachance","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1126\/science.abf8403","article-title":"Commensal Bacteria Promote Endocrine Resistance in Prostate Cancer through Androgen Biosynthesis","volume":"374","author":"Pernigoni","year":"2021","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41585-023-00795-2","article-title":"The Potential Role of the Microbiota in Prostate Cancer Pathogenesis and Treatment","volume":"20","author":"Pernigoni","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Fujita, K., Matsushita, M., De, M.A., Hatano, K., Minami, T., Norio, N., and Uemura, H. (2023). The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome. Cancers, 15.","DOI":"10.3390\/cancers15051375"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/pros.24776","article-title":"A Cross-Species Analysis of Fecal Microbiomes in Humans and Mice Reveals Similarities and Dissimilarities Associated with Prostate Cancer Risk","volume":"84","author":"Wakamori","year":"2024","journal-title":"Prostate"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1158\/1055-9965.EPI-21-0766","article-title":"Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort","volume":"31","author":"Reichard","year":"2022","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e70023","DOI":"10.1111\/cpr.70023","article-title":"Cutting-Edge Advancements in the Antibiotics-Gut Microbiota-Urinary Tumour Axis","volume":"58","author":"Wang","year":"2025","journal-title":"Cell Prolif."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut Microbiota Shapes Cancer Immunotherapy Responses","volume":"11","author":"Lei","year":"2025","journal-title":"npj Biofilms Microbiomes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41391-022-00536-3","article-title":"Gut Environment Changes Due to Androgen Deprivation Therapy in Patients with Prostate Cancer","volume":"26","author":"Kure","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"eabo2296","DOI":"10.1126\/science.abo2296","article-title":"A Microbiota-Modulated Checkpoint Directs Immunosuppressive Intestinal T Cells into Cancers","volume":"380","author":"Fidelle","year":"2023","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kustrimovic, N., Bombelli, R., Baci, D., and Mortara, L. (2023). Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021511"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pros.23713","article-title":"A Prospective Study to Examine the Association of the Urinary and Fecal Microbiota with Prostate Cancer Diagnosis after Transrectal Biopsy of the Prostate Using 16sRNA Gene Analysis","volume":"79","author":"Alanee","year":"2018","journal-title":"Prostate"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"563.e1","DOI":"10.1016\/j.clgc.2021.07.014","article-title":"Targeting the PI3K-AKT-mTOR Pathway in Castration Resistant Prostate Cancer: A Review Article","volume":"19","author":"Cham","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41391-020-0210-x","article-title":"Survival Outcomes and Risk Group Validation from SWOG S0925: A Randomized Phase II Study of Cixutumumab in New Metastatic Hormone-Sensitive Prostate Cancer","volume":"23","author":"Wong","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1078-0432.CCR-13-1869","article-title":"Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer","volume":"20","author":"Piulats","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/ijc.29576","article-title":"Metabolomic Analysis of Prostate Cancer Risk in a Prospective Cohort: The Alpha-tocopherol, Beta-carotene Cancer Prevention (ATBC) Study","volume":"137","author":"Mondul","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ijc.28641","article-title":"Effects of A-tocopherol and \u0392-carotene Supplementation on Cancer Incidence and Mortality: 18-Year Postintervention Follow-up of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study","volume":"135","author":"Virtamo","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Kim, H., Lee, J.E., Hong, S.H., Lee, M.A.h., Kang, J.H., and Kim, I.-H. (2019). The Effect of Antibiotics on the Clinical Outcomes of Patients with Solid Cancers Undergoing Immune Checkpoint Inhibitor Treatment: A Retrospective Study. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6267-z"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/annonc\/mdz206","article-title":"The Negative Impact of Antibiotics on Outcomes in Cancer Patients Treated with Immunotherapy: A New Independent Prognostic Factor?","volume":"30","author":"Elkrief","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1200\/JCO.22.00074","article-title":"Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study","volume":"41","author":"Eng","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Luu, M., Burkhard, S., Lauth, M., and Visekruna, A. (2023). The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment. Cancers, 15.","DOI":"10.3390\/cancers15051588"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41586-025-08937-9","article-title":"Diet Outperforms Microbial Transplant to Drive Microbiome Recovery in Mice","volume":"642","author":"Kennedy","year":"2025","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Yu, Y., Li, L., Yang, Q., Xue, J., Wang, B., Xie, M., Shangguan, W., Zhu, Z., and Wu, P. (2024). Akkermansia muciniphila Metabolite Inosine Inhibits Castration Resistance in Prostate Cancer. Microorganisms, 12.","DOI":"10.3390\/microorganisms12081653"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1158\/1538-7445.AM2024-5343","article-title":"Abstract 5343: Depletion of Gut Microbiota with Broad Spectrum Antibiotics Drives Pten-Null Prostate Cancer Growth in Mice","volume":"84","author":"De","year":"2024","journal-title":"Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2183685","DOI":"10.1080\/19490976.2023.2183685","article-title":"Circulating Androgen Regulation by Androgen-Catabolizing Gut Bacteria in Male Mouse Gut","volume":"15","author":"Hsiao","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"E1182","DOI":"10.1152\/ajpendo.00338.2019","article-title":"The Gut Microbiota Is a Major Regulator of Androgen Metabolism in Intestinal Contents","volume":"317","author":"Landin","year":"2019","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5534\/wjmh.210190","article-title":"Firmicutes in Gut Microbiota Correlate with Blood Testosterone Levels in Elderly Men","volume":"40","author":"Matsushita","year":"2022","journal-title":"World J. Men\u2019s Health"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/s41388-024-03073-6","article-title":"Role of Gut Microbiota in the Pathogenesis of Castration-Resistant Prostate Cancer: A Comprehensive Study Using Sequencing and Animal Models","volume":"43","author":"Lin","year":"2024","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"wrae101","DOI":"10.1093\/ismejo\/wrae101","article-title":"Pectin Supplementation Accelerates Post-Antibiotic Gut Microbiome Reconstitution Orchestrated with Reduced Gut Redox Potential","volume":"18","author":"Xu","year":"2024","journal-title":"ISME J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e02376-23","DOI":"10.1128\/spectrum.02376-23","article-title":"Short-Term Dietary Intervention with Whole Oats Protects from Antibiotic-Induced Dysbiosis","volume":"11","author":"Costa","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1038\/s41467-023-40553-x","article-title":"Fiber Supplementation Protects from Antibiotic-Induced Gut Microbiome Dysbiosis by Modulating Gut Redox Potential","volume":"14","author":"Penumutchu","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1097\/JU.0000000000003245.17","article-title":"MP20-17 Lard Diet Promotes Prostate Cancer Progression through Modulating Gut Microbiota and Intratumoral Lipid Metabolism","volume":"209","author":"Sato","year":"2023","journal-title":"J. Urol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s43856-024-00456-4","article-title":"A Phase IIb Randomized Placebo-Controlled Trial Testing the Effect of MAG-EPA Long-Chain Omega-3 Fatty Acid Dietary Supplement on Prostate Cancer Proliferation","volume":"4","author":"Robitaille","year":"2024","journal-title":"Commun. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pros.23706","article-title":"Omega-3 Fatty Acids Decrease Prostate Cancer Progression Associated with an Anti-Tumor Immune Response in Eugonadal and Castrated Mice","volume":"79","author":"Gevariya","year":"2018","journal-title":"Prostate"},{"key":"ref_63","first-page":"756","article-title":"Gut Microbiome Changes and Cancer Immunotherapy Outcomes Associated with Dietary Interventions: A Systematic Review of Preclinical and Clinical Evidence","volume":"23","author":"Somodi","year":"2025","journal-title":"PubMed"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12964-025-02275-z","article-title":"Combination Strategies of Gut Microbiota in Cancer Therapy through Metabolic Reprogramming and Immune Remodeling","volume":"23","author":"Wang","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut Microbiome Influences Efficacy of PD-1-Based Immunotherapy against Epithelial Tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium Promotes Antitumor Immunity and Facilitates Anti-PD-L1 Efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer Immunotherapy by CTLA-4 Blockade Relies on the Gut Microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3892\/ol.2024.14221","article-title":"Gut Microbiota Influences the Efficiency of Immune Checkpoint Inhibitors by Modulating the Immune System (Review)","volume":"27","author":"Jiang","year":"2024","journal-title":"Oncol. Lett."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JCO.2025.43.5_suppl.311","article-title":"Gut Health and Prostate Cancer: The Influence of a Specific Phytochemical-Rich Food Capsule plus or Minus a Probiotic\/Prebiotic Blend on Symptoms and Progression\u2014A Randomised, Double-Blind Placebo-Controlled Trial","volume":"45","author":"Thomas","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Balendra, V., Rosenfeld, R., Amoroso, C., Castagnone, C., Rossino, M.G., Garrone, O., and Ghidini, M. (2024). Postbiotics as Adjuvant Therapy in Cancer Care. Nutrients, 16.","DOI":"10.3390\/nu16152400"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"7855679","DOI":"10.1155\/jfbc\/7855679","article-title":"Lactobacillus acidophilus LA-5 Postbiotic Induces Apoptosis by Activating the Mitochondrial Apoptotic Pathway in Prostate Cancer","volume":"2024","author":"Akan","year":"2024","journal-title":"J. Food Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Miya, T., Marima, R., Damane, B.P., Ledet, E.M., and Dlamini, Z. (2023). Dissecting Microbiome-Derived SCFAs in Prostate Cancer: Analyzing Gut Microbiota, Racial Disparities, and Epigenetic Mechanisms. Cancers, 15.","DOI":"10.3390\/cancers15164086"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"104163","DOI":"10.1016\/j.ebiom.2022.104163","article-title":"Gut Microbiome in Modulating Immune Checkpoint Inhibitors","volume":"82","author":"Li","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1158\/2767-9764.CRC-24-0543","article-title":"Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study","volume":"5","author":"Sawada","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s12602-023-10045-x","article-title":"The Current and Future Perspectives of Postbiotics","volume":"15","author":"Liang","year":"2023","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"\u017b\u00f3\u0142kiewicz, J., Marzec, A., Ruszczy\u0144ski, M., and Feleszko, W. (2020). Postbiotics\u2014A Step Beyond Pre- and Probiotics. Nutrients, 12.","DOI":"10.3390\/nu12082189"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41422-024-01053-9","article-title":"Triaptosis: An Endosome-Dependent Cell Death Modality","volume":"35","author":"Tang","year":"2024","journal-title":"Cell Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"eadk9167","DOI":"10.1126\/science.adk9167","article-title":"Dietary Pro-Oxidant Therapy by a Vitamin K Precursor Targets PI 3-Kinase VPS34 Function","volume":"386","author":"Swamynathan","year":"2024","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e17054","DOI":"10.1200\/JCO.2023.41.16_suppl.e17054","article-title":"The Association between Antibiotics Administration and Outcomes in Men with Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: Secondary Analysis of Two Randomized Clinical Trials","volume":"41","author":"Ni","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e012659","DOI":"10.1136\/jitc-2025-012659","article-title":"Improved Survival in Advanced Melanoma Patients Treated with Fecal Microbiota Transplantation Using Healthy Donor Stool in Combination with Anti-PD1: Final Results of the MIMic Phase 1 Trial","volume":"13","author":"Hadi","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/intimm\/dxaf038","article-title":"Akihito Nagahara Fecal Microbiota Transplantation for Immune Regulation: Improving Ulcerative Colitis and Enhancing Cancer Immunotherapy","volume":"38","author":"Zhang","year":"2025","journal-title":"Int. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Yan, J., Yang, L., Ren, Q., Zhu, C., Du, H., Wang, Z., Qi, Y., Xian, X., and Chen, D. (2024). Gut Microbiota as a Biomarker and Modulator of Anti-Tumor Immunotherapy Outcomes. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1471273"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Lin, A., Huang, L., Jiang, A., Zhu, L., Mou, W., Li, Y., Zhang, C., Liu, Z., Zhang, J., and Cheng, Q. (2025). Microbiota Boost Immunotherapy? A Meta-Analysis Dives into Fecal Microbiota Transplantation and Immune Checkpoint Inhibitors. BMC Med., 23.","DOI":"10.1186\/s12916-025-04183-y"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e20250378","DOI":"10.1084\/jem.20250378","article-title":"Microbiota-Centered Interventions to Boost Immune Checkpoint Blockade Therapies","volume":"222","author":"Almonte","year":"2025","journal-title":"J. Exp. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s11864-022-01027-2","article-title":"Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light","volume":"23","author":"Zhang","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ccell.2025.07.012","article-title":"Tumor-Resident Probiotic Clostridium butyricum Improves aPD-1 Efficacy in Colorectal Cancer Models by Inhibiting IL-6-Mediated Immunosuppression","volume":"43","author":"Xie","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin\/\u03b2-Catenin Signaling via Its FadA Adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"101478","DOI":"10.1016\/j.xcrm.2024.101478","article-title":"Modulating Gut Microbiome in Cancer Immunotherapy: Harnessing Microbes to Enhance Treatment Efficacy","volume":"5","author":"Kang","year":"2024","journal-title":"Cell Rep. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/998\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:27:23Z","timestamp":1774070843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":88,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18060998"],"URL":"https:\/\/doi.org\/10.3390\/cancers18060998","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}